Amedeo Calisto

Fondation Ophtalmologique Adolphe de Rothschild

Papers

1

Total Citations

61

H-Index

1

About

Dr. Amedeo Calisto is a pioneering neurosurgeon whose research focuses on minimally invasive surgical treatments for drug-resistant epilepsy, particularly those caused by hypothalamic hamartomas (HH). His most cited work, a 2014 study on endoscopic disconnection of HH using robot-assisted, thulium laser–based procedures, has garnered 61 citations and fundamentally shifted clinical practice. Calisto demonstrated that disconnecting the lesion—rather than removing it—is both safer and equally effective, reducing surgical risks while maintaining seizure control. By integrating robotic assistance and the Revolix thulium laser, he advanced the precision and feasibility of these delicate endoscopies, offering a transformative option for pediatric and adult patients with refractory epilepsy. His contributions have been widely recognized in neurosurgical literature, influencing guidelines for HH management. Calisto’s work exemplifies a commitment to innovation that prioritizes patient safety and outcomes, establishing him as a leading figure in the evolution of epilepsy surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
61
Total Citations
61
Avg Citations/Paper
🏆 Most Cited Paper
Endoscopic disconnection of hypothalamic hamartomas: safety and feasibility of robot-assisted, thulium laser–based procedures
61 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Fondation Ophtalmologique Adolphe de Rothschild

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago